- Actavis
Infobox Company
company_name = Actavis Group
company_
company_type = Private
foundation =1956
location =Hafnarfjörður ,Iceland
num_employees = 11,000
key_people =Sigurður Óli Ólafsson (CEO)
revenue = $2 billion (December 2005)
industry =Pharmaceutical
products =
homepage = [http://www.actavis.com/ www.actavis.com]Actavis is an international generic pharmaceutical company founded in 1956 as Pharmaco. It is headquartered in
Iceland and listed on the Icelandic Stock Exchange.In the late 1990s, Actavis employed fewer than one hundred people and operated solely in the Icelandic market. In 1999, Actavis acquired Bulgarian rival Balkanpharma, beginning a period of substantial growth.
Since then, Actavis has made 25 acquisitions and now operates in 40 countries and employees over 11,000 people. The Group has one of the broadest portfolios in the generics sector with over 650 products on the market, in addition to over 400 products in the development pipeline and in registration.
Actavis is currently among the five largest generic pharmaceutical companies in the world. Its turnover for
2006 is predicted to be 1,390 million euros, compared to 56 million euros in1999 .The chairman of the company is Icelandic businessman
Björgólfur Thor Björgólfsson . Robert Wessman became President and CEO of Actavis following the company’s merger with Delta in 2002, where he had served as CEO since1999 . A business graduate and lecturer at theUniversity of Iceland , Wessman worked previously at Icelandic transportation company Samskip, advancing to the post of CEO inGermany . Robert is also a Board Member of the IcelandicChamber of Commerce .On the 24th of November 2006, Actavis announced the departure of Svafa Gronfeldt, Deputy to the CEO. She leaves Actavis to pursue a new position as Dean of
Reykjavik University . Sigurður Óli Ólafson takes her place as Deputy to the CEO. On 5th August 2008, Róbert Wessmann stepped down as the CEO to focus on his personal investments through his company, Salt Investments. Sigurður Óli Ólafsson took his place as CEO.One noteworthy service offered by Actavis is the "
Evidence-based medicine (EBM) Research Service". The service is free of charge for registeredMedical Doctors (MD's) and is offered out of Austria and Switzerland. A registered MD can send a research inquiry to an Actavis team of specialists from Austrian universities, who will research the topic and provide a research report to back to the MD.External links
* [http://www.actavis.com/ Actavis corporate website]
* [http://www.actavis.com.mt/ Actavis Malta]
* [http://www.actavis.bg/ Actavis Bulgaria]
* [http://www.zdravlje.co.yu/ Actavis Serbia]
Wikimedia Foundation. 2010.
